May-31-23 04:17AM |
Top Stock Reports for FEMSA, NextEra Energy & SanofiZacks Investment Research |
06:20AM |
Should You Invest in the VanEck Biotech ETF (BBH)?Zacks Investment Research |
May-08-23 08:16AM |
American Express, Gilead Sciences And This US Oil Giant On CNBC's 'Final Trades'Benzinga |
May-04-23 07:50AM |
Gilead Sciences Stock Has Only Done This in 1 of the Past 7 YearsThe Motley Fool |
May-01-23 08:05AM |
Expert Ratings for Gilead SciencesBenzinga |
Apr-28-23 03:34AM |
Gilead Sciences (GILD) Q1 2023 Earnings Call TranscriptThe Motley Fool |
01:07AM |
Gilead's (GILD) Q1 Earnings Miss, Veklury Sales PlungeZacks Investment Research |
Apr-28-23 08:17AM |
Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighsMarketWatch |
Apr-27-23 09:15AM |
Gilead shares fall after mixed results, as weaker COVID-19 drug remand weighsMarketWatch |
09:33AM |
Debt Limit Bill Heads To Senate To Be RejectedBenzinga |
Apr-27-23 05:30AM |
Better Buy: Pfizer vs. GileadThe Motley Fool |
Apr-26-23 09:28AM |
Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & MoreZacks Investment Research |
Apr-25-23 10:01AM |
Incyte (INCY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research |
09:45AM |
This Supercharged Dividend King Stock Might Soon Run Out of SteamThe Motley Fool |
Apr-25-23 07:45AM |
2 Excellent Dividend Stocks to Buy for Less Than $100The Motley Fool |
Apr-24-23 01:15AM |
S&P 500: Signs of a New Bull Market Keep MountingInvesting.com |
07:27AM |
Big Tech Earnings & Economic Numbers: 3 Ways to Survive the Week AheadZacks Investment Research |
Apr-21-23 12:55PM |
Will HIV and Oncology Propel Gilead's (GILD) Q1 Earnings?Zacks Investment Research |
07:59AM |
Berkshire Hathaway, Gilead Sciences, Vertex Pharmaceuticals And A Break-Out Casino Stock Feature On CNBC's 'Final Trades'Benzinga |
Apr-20-23 10:03AM |
Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research |
Apr-12-23 03:00AM |
Expert Ratings for Gilead SciencesBenzinga |
05:31AM |
Could Gilead Sciences Stock Help You Become a Millionaire?The Motley Fool |
Apr-12-23 12:11PM |
DivHut Portfolio Update: March 2023Seeking Alpha |
Apr-11-23 06:20AM |
Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now?Zacks Investment Research |
Apr-10-23 09:15AM |
If You Invested $10,000 in Gilead Sciences in 2013, This Is How Much You Would Have TodayThe Motley Fool |
Apr-07-23 06:20AM |
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?Zacks Investment Research |
Apr-06-23 01:49AM |
Post-Pandemic Potential: Analysts Eye InflaRx COVID-19 Antibody For Market BreakthroughBenzinga |
10:23AM |
Here's Why You Should Add Ligand (LGND) Stock to Your PortfolioZacks Investment Research |
Apr-06-23 08:15AM |
6 Reasons to Buy Gilead Sciences StockThe Motley Fool |
Apr-05-23 03:09AM |
U.S. Wide-Moat Stocks On Sale - The April 2023 Heat MapSeeking Alpha |
Apr-03-23 12:03PM |
Bristol Myers' (BMY) Breyanzi Gets Positive CHMP OpinionZacks Investment Research |
06:20AM |
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?Zacks Investment Research |
Mar-31-23 06:20AM |
Should Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) Be on Your Investing Radar?Zacks Investment Research |
Mar-29-23 04:00AM |
Is It Time to Buy These Ultra-Cheap Dividend Stocks?The Motley Fool |
03:42AM |
Why Are Cathie Wood's Ark ETFs Still Trailing Nasdaq Stocks?Benzinga |
Mar-29-23 07:45AM |
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to RunThe Motley Fool |
Mar-27-23 09:27AM |
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend YieldsBenzinga |
08:34AM |
Bunge, Gilead Sciences And A Famous Chocolate Maker On CNBC's 'Final Trades'Benzinga |
Mar-27-23 06:20AM |
Should You Invest in the VanEck Biotech ETF (BBH)?Zacks Investment Research |
Mar-23-23 01:51AM |
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug ApprovalZacks Investment Research |
06:20AM |
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?Zacks Investment Research |
Mar-23-23 06:20AM |
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?Zacks Investment Research |
Mar-22-23 02:38AM |
Gilead (GILD) Announces OS Data on Yescarta From ZUMA-7 StudyZacks Investment Research |
10:07AM |
A Bull Market Is Coming: Load Up On These 3 Cheap Stocks TodayThe Motley Fool |
Mar-22-23 06:20AM |
Should SPDR Russell 1000 Yield Focus ETF (ONEY) Be on Your Investing Radar?Zacks Investment Research |
Mar-21-23 02:47AM |
Gilead (GILD) Exercises Option to License Nurix's CandidateZacks Investment Research |
10:05AM |
Nurix's (NRIX) Stock Up Due to License Option Exercise by GileadZacks Investment Research |
Mar-20-23 11:56AM |
First Republic Bank's stock plummets and Peloton's stock falls while New York Community Bank shares soar, and other stocks on the moveMarketWatch |
Mar-16-23 12:10PM |
Gilead (GILD) Gains 34% in 12 Months: Will the Trend Sustain?Zacks Investment Research |
Mar-15-23 06:20AM |
Is SPDR Russell 1000 Yield Focus ETF (ONEY) a Strong ETF Right Now?Zacks Investment Research |